{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:29:10Z","timestamp":1786400950198,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.1038\/s41388-026-03888-5","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:24:39Z","timestamp":1783679079000},"page":"3413-3426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting of solute carrier family 1 member 1 that links metabolic reprogramming and ferroptosis sensitivity in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Jie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3144-5034","authenticated-orcid":false,"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3888_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:7\u201324.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3888_CR2","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/ijms25052860","volume":"25","author":"DJ Jimenez","year":"2024","unstructured":"Jimenez DJ, Javed A, Rubio-Tomas T, Seye-Loum N, Barcelo C. Clinical and preclinical targeting of oncogenic pathways in PDAC: targeted therapeutic approaches for the deadliest cancer. Int J Mol Sci. 2024;25:2860.","journal-title":"Int J Mol Sci"},{"key":"3888_CR3","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1038\/s41388-022-02448-x","volume":"41","author":"T Evan","year":"2022","unstructured":"Evan T, Wang VM, Behrens A. The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. Oncogene. 2022;41:4686\u201395.","journal-title":"Oncogene"},{"key":"3888_CR4","doi-asserted-by":"publisher","first-page":"411.","DOI":"10.3390\/cancers15020411","volume":"15","author":"G Lauria","year":"2023","unstructured":"Lauria G, Curcio R, Lunetti P, Tiziani S, Coppola V, Dolce V, et al. Role of mitochondrial transporters on metabolic rewiring of pancreatic adenocarcinoma: a comprehensive review. Cancers (Basel). 2023;15:411.","journal-title":"Cancers (Basel)"},{"key":"3888_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, Mockabee-Macias A, Jiang C, Falzone A, Prieto-Farigua N, Stone E, et al. Non-canonical glutamate-cysteine ligase activity protects against ferroptosis. Cell Metab. 2021;33:174\u201389.e7.","journal-title":"Cell Metab"},{"key":"3888_CR6","doi-asserted-by":"publisher","first-page":"14979.","DOI":"10.3390\/ijms241914979","volume":"24","author":"C Lopez-Blazquez","year":"2023","unstructured":"Lopez-Blazquez C, Lacalle-Gonzalez C, Sanz-Criado L, Ochieng\u2019 Otieno M, Garcia-Foncillas J, Martinez-Useros J. Iron-dependent cell death: a new treatment approach against pancreatic ductal adenocarcinoma. Int J Mol Sci. 2023;24:14979.","journal-title":"Int J Mol Sci"},{"key":"3888_CR7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00018-013-1484-0","volume":"71","author":"MG Bianchi","year":"2014","unstructured":"Bianchi MG, Bardelli D, Chiu M, Bussolati O. Changes in the expression of the glutamate transporter EAAT3\/EAAC1 in health and disease. Cell Mol Life Sci. 2014;71:2001\u201315.","journal-title":"Cell Mol Life Sci"},{"key":"3888_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/0008-5472.CAN-20-0617","volume":"81","author":"W Guo","year":"2021","unstructured":"Guo W, Li K, Sun B, Xu D, Tong L, Yin H, et al. Dysregulated glutamate transporter SLC1A1 propels cystine uptake via Xc(-) for glutathione synthesis in lung cancer. Cancer Res. 2021;81:552\u201366.","journal-title":"Cancer Res"},{"key":"3888_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, et al. HIF-1alpha drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023;42:112945.","journal-title":"Cell Rep"},{"key":"3888_CR10","doi-asserted-by":"publisher","first-page":"e55146","DOI":"10.15252\/embr.202255146","volume":"23","author":"B Dehingia","year":"2022","unstructured":"Dehingia B, Milewska M, Janowski M, Pekowska A. CTCF shapes chromatin structure and gene expression in health and disease. EMBO Rep. 2022;23:e55146.","journal-title":"EMBO Rep"},{"key":"3888_CR11","doi-asserted-by":"publisher","first-page":"1357.","DOI":"10.3390\/cells12101357","volume":"12","author":"A Del Moral-Morales","year":"2023","unstructured":"Del Moral-Morales A, Salgado-Albarran M, Sanchez-Perez Y, Wenke NK, Baumbach J, Soto-Reyes E. CTCF and its multi-partner network for chromatin regulation. Cells. 2023;12:1357.","journal-title":"Cells"},{"key":"3888_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.654","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang X, Zhu Y, Cao Y, Wang L, Li F, et al. The CTCF\/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression. Clin Transl Med. 2022;12:e654.","journal-title":"Clin Transl Med"},{"key":"3888_CR13","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1158\/1078-0432.CCR-18-0290","volume":"24","author":"I Peran","year":"2018","unstructured":"Peran I, Madhavan S, Byers SW, McCoy MD. Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms. Clin Cancer Res. 2018;24:3813\u20139.","journal-title":"Clin Cancer Res"},{"key":"3888_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64734-y","volume":"16","author":"B Wang","year":"2025","unstructured":"Wang B, Han X, Lin X, Wang J, You C, Chen K, et al. The integral membrane protein smim4 modulates redox balance via malate compartmentalization in pancreatic cancer. Nat Commun. 2025;16:9772.","journal-title":"Nat Commun"},{"key":"3888_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/ars.2022.0203","volume":"39","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang Y, Lin Z, Kang R, Tang D, Liu J. SLC25A22 as a key mitochondrial transporter against ferroptosis by producing glutathione and monounsaturated fatty acids. Antioxid Redox Signal. 2023;39:166\u201385.","journal-title":"Antioxid Redox Signal"},{"key":"3888_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","volume":"11","author":"R Francescone","year":"2021","unstructured":"Francescone R, Barbosa Vendramini-Costa D, Franco-Barraza J, Wagner J, Muir A, Lau AN, et al. Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression. Cancer Discov. 2021;11:446\u201379.","journal-title":"Cancer Discov"},{"key":"3888_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106555","volume":"187","author":"F Li","year":"2023","unstructured":"Li F, He C, Yao H, Zhao Y, Ye X, Zhou S, et al. Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification. Pharm Res. 2023;187:106555.","journal-title":"Pharm Res"},{"key":"3888_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1080\/15548627.2021.1922984","volume":"17","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Kimmelman AC. Autophagy is critical for cysteine metabolism in pancreatic cancer through regulation of SLC7A11. Autophagy. 2021;17:1561\u20132.","journal-title":"Autophagy"},{"key":"3888_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217726","volume":"623","author":"H Zhang","year":"2025","unstructured":"Zhang H, Ma T, Wen X, Jiang J, Chen J, Jiang J, et al. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Cancer Lett. 2025;623:217726.","journal-title":"Cancer Lett"},{"key":"3888_CR20","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775\u201389.","journal-title":"Genome Res"},{"key":"3888_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tig.2017.04.004","volume":"33","author":"IW Deveson","year":"2017","unstructured":"Deveson IW, Hardwick SA, Mercer TR, Mattick JS. The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome. Trends Genet. 2017;33:464\u201378.","journal-title":"Trends Genet"},{"key":"3888_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52981-w","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang DY, Bu KN, Gao JD, Zhang BL. Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature. Sci Rep. 2024;14:2859.","journal-title":"Sci Rep"},{"key":"3888_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103614","volume":"72","author":"J Xiong","year":"2021","unstructured":"Xiong J, Wang N, Zhong HJ, Cui BW, Cheng S, Sun R, et al. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential. EBioMedicine. 2021;72:103614.","journal-title":"EBioMedicine"},{"key":"3888_CR24","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.3390\/ijms25147544","volume":"25","author":"J Fujii","year":"2024","unstructured":"Fujii J, Imai H. Oxidative metabolism as a cause of lipid peroxidation in the execution of ferroptosis. Int J Mol Sci. 2024;25:7544.","journal-title":"Int J Mol Sci"},{"key":"3888_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"Badgley MA","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368:85\u20139.","journal-title":"Science"},{"key":"3888_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.865655","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huang Z, Cheng J, Pan H, Lin T, Shen X, et al. Platelet-vesicles-encapsulated RSL-3 enable anti-angiogenesis and induce ferroptosis to inhibit pancreatic cancer progress. Front Endocrinol (Lausanne). 2022;13:865655.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3888_CR27","doi-asserted-by":"publisher","first-page":"e22584","DOI":"10.1016\/j.heliyon.2023.e22584","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Qi W, Yin J, He X, Duan S, Bao H, et al. High CTCF expression mediated by FGD5-AS1\/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. Heliyon. 2023;9:e22584.","journal-title":"Heliyon"},{"key":"3888_CR28","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41388-019-0918-z","volume":"38","author":"WX Peng","year":"2019","unstructured":"Peng WX, He RZ, Zhang Z, Yang L, Mo YY. LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription. Oncogene. 2019;38:6770\u201380.","journal-title":"Oncogene"},{"key":"3888_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003705","volume":"9","author":"FC Beckedorff","year":"2013","unstructured":"Beckedorff FC, Ayupe AC, Crocci-Souza R, Amaral MS, Nakaya HI, Soltys DT, et al. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet. 2013;9:e1003705.","journal-title":"PLoS Genet"},{"key":"3888_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/15592294.2019.1615355","volume":"14","author":"N Calanca","year":"2019","unstructured":"Calanca N, Paschoal AP, Munhoz EP, Galindo LT, Barbosa BM, Caldeira JRF, et al. The long non-coding RNA ANRASSF1 in the regulation of alternative protein-coding transcripts RASSF1A and RASSF1C in human breast cancer cells: implications to epigenetic therapy. Epigenetics. 2019;14:741\u201350.","journal-title":"Epigenetics"},{"key":"3888_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64983-x","volume":"16","author":"T Grubb","year":"2025","unstructured":"Grubb T, Koochaki P, Matar S, Ghandour F, Machaalani M, Saad E, et al. The SLC1A1\/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs. Nat Commun. 2025;16:10012.","journal-title":"Nat Commun"},{"key":"3888_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41422-022-00650-w","volume":"32","author":"X Wang","year":"2022","unstructured":"Wang X, Chen Z, Xu J, Tang S, An N, Jiang L, et al. SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors. Cell Res. 2022;32:638\u201358.","journal-title":"Cell Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03888-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03888-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03888-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:02:12Z","timestamp":1786399332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03888-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":32,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["3888"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03888-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}